A greater reduction in body weight, cholesterol, triglycerides, fasting glucose, insulin, and HOMA-IR was achieved with the higher dose of tirzepatide, demonstrating a clear dose-dependent improvement
Researchers stress the need for independent studies before these treatments can be fully embraced worldwide
If you are actively working on body composition with tirzepatide and tracking your results , be aware that as you lose weight, your subcutaneous fat layer changes
Administration of omega-6-FA lead to an increase of the KYN/TRP ratio by week 6, but by week 12 the increase was marginally significant (p = 0.051)
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF